APA (7th ed.) Citation

Forcheron, F., Cachefo, A., Thevenon, S., Pinteur, C., & Beylot, M. (2002). Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients. Diabetes (New York, N.Y.), 51(12), 3486-3491. https://doi.org/10.2337/diabetes.51.12.3486

Chicago Style (17th ed.) Citation

Forcheron, Fabien, Ana Cachefo, Sylvie Thevenon, Claudie Pinteur, and Michel Beylot. "Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients." Diabetes (New York, N.Y.) 51, no. 12 (2002): 3486-3491. https://doi.org/10.2337/diabetes.51.12.3486.

MLA (9th ed.) Citation

Forcheron, Fabien, et al. "Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients." Diabetes (New York, N.Y.), vol. 51, no. 12, 2002, pp. 3486-3491, https://doi.org/10.2337/diabetes.51.12.3486.